XML 35 R21.htm IDEA: XBRL DOCUMENT v3.23.2
Equity Incentive Plan (Tables)
6 Months Ended
Jun. 30, 2023
Schedule of Additional Information on Stock Option Grants And Vesting

The following table summarizes additional information on stock option grants and vesting (in thousands):

 

 

 

2019 Plan

 

 

 

Six Months Ended June 30, 2023

 

 

Six Months Ended June 30, 2022

 

Total fair value of stock options granted

 

$

938

 

 

$

2,898

 

Total fair value of options vested

 

 

1,682

 

 

 

840

 

Schedule of Black Scholes model for the Private Warrants The following table summarizes the assumptions used in the valuation models to determine the fair value of awards granted to employees and non-employee directors under the 2019 Plan:

 

 

 

Six Months Ended June 30, 2023

 

 

Six Months Ended June 30, 2022

 

Expected volatility

 

 

41.2

%

 

42.8% - 42.9%

 

Expected term (in years)

 

 

6.00

 

 

6.00

 

Dividend yield

 

 

0.00

%

 

 

0.00

%

Risk-free interest rate

 

 

3.61

%

 

1.62% - 2.71%

 

Stock Based Compensation Expense Included In Condensed Consolidated Statements of Comprehensive Loss

Stock-based compensation expense is included in the Company’s Condensed Consolidated Statements of Comprehensive Loss within the following line items (in thousands):

 

 

 

Three Months Ended June 30, 2023

 

 

Three Months Ended June 30, 2022

 

 

Six Months Ended June 30, 2023

 

 

Six Months Ended June 30, 2022

 

Cost of revenues

 

$

244

 

 

$

411

 

 

$

471

 

 

$

762

 

General and administrative

 

 

453

 

 

 

511

 

 

 

897

 

 

 

919

 

Research and development

 

 

94

 

 

 

134

 

 

 

170

 

 

 

237

 

Sales and marketing

 

 

86

 

 

 

241

 

 

 

172

 

 

 

441

 

Total

 

$

877

 

 

$

1,297

 

 

$

1,710

 

 

$

2,359

 

Restricted Stock Units [Member]  
Schedule of RSUs Activity Under 2019 Plan

The following table summarizes the Company’s RSU activity for performance based RSUs awarded to employees and for time-based RSUs granted to non-employee directors under the 2019 Plan:

Description

 

RSUs
Outstanding

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining Contractual Term (Years)

 

RSUs non-vested, December 31, 2022

 

 

1,876,669

 

 

$

6.45

 

 

 

6.10

 

Granted

 

 

786,884

 

 

 

2.04

 

 

 

 

Vested

 

 

(190,059

)

 

 

6.52

 

 

 

 

Forfeited

 

 

(23,724

)

 

 

6.40

 

 

 

 

Expired

 

 

 

 

 

 

 

 

 

RSUs non-vested, June 30, 2023

 

 

2,449,770

 

 

$

5.03

 

 

 

5.89

 

2019 Plan [Member]  
Schedule of Stock Option Activity Under 2019 Plan

The following table summarizes the Company’s stock option activity under the 2019 Plan:

 

Description

 

Options
Outstanding

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term (Years)

 

 

Aggregate
Intrinsic
Value (1)

 

Options outstanding, December 31, 2022

 

 

5,757,779

 

 

$

7.92

 

 

 

7.60

 

 

$

 

Granted

 

 

987,796

 

 

 

1.05

 

 

 

 

 

 

1,183,255

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(17,405

)

 

 

6.15

 

 

 

 

 

 

 

Expired

 

 

(137,398

)

 

 

8.07

 

 

 

 

 

 

 

Options outstanding, June 30, 2023

 

 

6,590,772

 

 

$

6.89

 

 

 

7.58

 

 

$

1,183,255

 

Options vested and exercisable, June 30, 2023

 

 

4,480,069

 

 

$

8.20

 

 

 

6.92

 

 

$

 

Options vested and expected to vest, June 30, 2023

 

 

6,590,772

 

 

$

6.89

 

 

 

7.58

 

 

$

1,183,255

 

_______________________________

(1)
Aggregate intrinsic value (in thousands) represents the difference between the estimated fair value of the underlying Common Stock and the exercise price of outstanding in-the-money options.